Although the cfDNA-related fluorescence indicator FERST8 had the maximum AUROC (0.801) for differentiating HCC from BLD in all single indicators, including serum fluorescence intensity, AFP and hepatic function tests, this indicator is not ideal in clinical application. This evidence concerns the gene AFP and hepatocellular carcinoma.